Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
MRTXShowing 0 of 16 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in MIRATI THERAPEUTICS INC
As of its Q4 2023 13F, Farallon Capital Management held 2,024,472 shares of MRTX (Mirati Therapeutics), worth $118.9M. Farallon Capital Management's 13F filings listed MRTX from Q3 2023 to Q4 2023, 2 quarterly filings. MRTX was 0.5% of Farallon Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of MRTX: Avoro Capital Advisors LLC